medigraphic.com
ISSN 2992-8559 (Electronic)
ISSN 1405-0625 (Print)

2022, Number 1

<< Back

Cir Plast 2022; 32 (1)

Gigantomastia associated with pseudoangiomatous stromal hyperplasia

Quiñones-Zamudio O, González-Martínez J, Hinojosa-Paniagua JR

Language: Spanish
References: 23
Page: 58-64
PDF size: 467.65 Kb.


ABSTRACT

Gigantomastia is a pathology that we treat frequently, which is why it is important to know the different problems that we can face. We report a case of gigantomastia where the reduction mammoplasty access with the superior pedicle technique was modified, due to intraoperative findings, to a total mastectomy with free nipple grafting. The resection of 4.8 kg in the right breast and 3.4 kg in the left breast was performed. The final histopathological study with immunohistochemistry reported pseudoangiomatous stromal hyperplasia, a rare disease that can present in the breast in a localized, diffuse, unilateral, or bilateral manner. The patient was followed up for a year without performing reconstructive management, since pseudoangiomatous stromal hyperplasia has a high recurrence rate when complete resection of the breast tissue has not been performed. In this case breast reconstruction with fat grafting was performed in three surgical procedures.


REFERENCES

  1. Dafydd H, Roehl KR, Phillips LG, Dancey A, Peart F, Shokrollahi K. Redefining gigantomastia. J Plast Reconstr Aesthet Surg 2011; 64 (2): 160-163.

  2. Dancey A, Khan M, Dawson J, Peart F. Gigantomastia--a classification and review of the literature. J Plast Reconstr Aesthet Surg 2008; 61 (5): 493-502.

  3. Vuitch MF, Rosen PP, Erlandson RA. Pseudoangiomatous hyperplasia of mammary stroma. Hum Pathol 1986; 17 (2): 185-191.

  4. Machado M, Garzón A, Muñoz V, Flores Turk MG. Hiperplasia estromal pseudoangiomatosa de la mama (PASH): presentación de dos casos. Revista Argentina de Radiología 2009; 73 (4): 433-436.

  5. Hanby AM, Walker C, Tavassoli FA, Devilee P. Pathology and genetics: tumors of the breast and female genital organs. WHO Classification of Tumors series - volume IV. Lyon, France: IARC Press. Breast Cancer Res 2004; 6: 133.

  6. Taira N, Ohsumi S, Aogi K et al. Nodular pseudoangiomatous stromal hyperplasia of mammary stroma in a case showing rapid tumor growth. Breast Cancer 2005; 12 (4): 331-336.

  7. Amenomori M, Hayashi T, Abe K, Itoyanagi N, Kohno S. A case of pseudoangiomatous stromal hyperplasia of the breast presenting with chest pain. The Open Breast Cancer Journal 2009; 1: 10-13.

  8. Powell CM, Cranor ML, Rosen PP. Pseudoangiomatous stromal hyperplasia (PASH). A mammary stromal tumor with myofibroblastic differentiation. Am J Surg Pathol 1995; 19 (3): 270-277.

  9. Wieman SM, Landercasper J, Johnson JM et al. Tumoral pseudoangiomatous stromal hyperplasia of the breast. Am Surg 2008; 74 (12): 1211-1214.

  10. Virk RK, Khan A. Pseudoangiomatous stromal hyperplasia: an overview. Arch Pathol Lab Med 2010; 134 (7): 1070-1074.

  11. Bowman E, Oprea G, Okoli J et al. Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients. Breast J 2012; 18 (3):242-247.

  12. Yoo K, Woo OH, Yong HS et al. Fast-growing pseudoangiomatous stromal hyperplasia of the breast: report of a case. Surg Today 2007; 37 (11): 967-970.

  13. Anderson C, Ricci A Jr, Pedersen CA, Cartun RW. Immunocytochemical analysis of estrogen and progesterone receptors in benign stromal lesions of the breast. Evidence for hormonal etiology in pseudoangiomatous hyperplasia of mammary stroma. Am J Surg Pathol 1991; 15 (2): 145-149.

  14. Zanella M, Falconieri G, Lamovec J, Bittesini L. Pseudoangiomatous hyperplasia of the mammary stroma: true entity or phenotype? Pathol Res Pract 1998; 194 (8): 535-540.

  15. Ferreira M, Albarracin CT, Resetkova E. Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic, and pathologic study of 26 cases. Mod Pathol 2008; 21 (2): 201-207.

  16. Polger MR, Denison CM, Lester S, Meyer JE. Pseudoangiomatous stromal hyperplasia: mammographic and sonographic appearances. AJR Am J Roentgenol 1996; 166 (2): 349-352.

  17. Jones KN, Glazebrook KN, Reynolds C. Pseudoangiomatous stromal hyperplasia: imaging findings with pathologic and clinical correlation. AJR Am J Roentgenol 2010; 195 (4): 1036-1042.

  18. Goel NB, Knight TE, Pandey S, Riddick-Young M, de Paredes ES, Trivedi A. Fibrous lesions of the breast: imaging-pathologic correlation. Radiographics 2005; 25 (6): 1547-1559.

  19. Kling RE, Tobler WD Jr, Gusenoff JA, Rubin JP. Avoiding complications in gigantomastia. Clin Plast Surg 2016; 43 (2): 429-439.

  20. Jaunoo SS, Thrush S, Dunn P. Pseudoangiomatous stromal hyperplasia (PASH): a brief review. Int J Surg 2011; 9 (1): 20-22.

  21. Jung BK, Nahm JH, Lew DH, Lee DW. Treatment of pseudoangiomatous stromal hyperplasia of the breast: implant-based reconstruction with a vascularized dermal sling. Arch Plast Surg 2015; 42 (5): 630-634.

  22. Oppenheimer AJ, Oppenheimer DC, Fiala TG, Noori S. Pseudoangiomatous stromal hyperplasia: a rare cause of idiopathic gigantomastia. Plast Reconstr Surg Glob Open 2016; 4 (1):e593.

  23. Pruthi S, Reynolds C, Johnson RE, Gisvold JJ. Tamoxifen in the management of pseudoangiomatous stromal hyperplasia. Breast J 2001; 7 (6): 434-439.




2020     |     www.medigraphic.com